Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON-AA: Apixaban and Clopidogrel for Recurrent Ischemic Stroke Prevention
NCT07237308Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in ischemic stroke, sponsored by Yonsei University. Started Jul 2026; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07237308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07237308.